100 related articles for article (PubMed ID: 20054341)
1. IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Prochazkova-Carlotti M; Vergier B; Petrella T; Grange F; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 May; 130(5):1470-2. PubMed ID: 20054341
[No Abstract] [Full Text] [Related]
2. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
Menguy S; Laharanne E; Prochazkova-Carlotti M; Gros A; Vergier B; Parrens M; Beylot-Barry M; Pham-Ledard A; Merlio JP
Am J Surg Pathol; 2020 Mar; 44(3):424-427. PubMed ID: 31764222
[No Abstract] [Full Text] [Related]
4. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
[TBL] [Abstract][Full Text] [Related]
5. B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.
Zhou L; Gu B; Shen X; Binshen O; Dong L; Zhou J; Yi H; Wang C
Pathol Int; 2021 Mar; 71(3):183-190. PubMed ID: 33503299
[TBL] [Abstract][Full Text] [Related]
6. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.
Pham-Ledard A; Prochazkova-Carlotti M; Andrique L; Cappellen D; Vergier B; Martinez F; Grange F; Petrella T; Beylot-Barry M; Merlio JP
Mod Pathol; 2014 Mar; 27(3):402-11. PubMed ID: 24030746
[TBL] [Abstract][Full Text] [Related]
7. Early pattern of large B-cell lymphoma with IRF4 rearrangement.
Granai M; Lazzi S
Blood; 2020 Aug; 136(6):769. PubMed ID: 32761226
[No Abstract] [Full Text] [Related]
8. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
[TBL] [Abstract][Full Text] [Related]
9.
Büyüktaş D; Örnek S; Tokat F; Tecimer T; Ferhanoğlu B
Turk J Haematol; 2020 Nov; 37(4):292-294. PubMed ID: 32349466
[No Abstract] [Full Text] [Related]
10. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
11. Unusual clinicopathological presentation of primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple nodules and widespread garland-like lesions.
Belousova IE; Vanecek T; Skreg SV; Rodionov AN; Samtsov AV; Kazakov DV
Am J Dermatopathol; 2009 Jun; 31(4):370-4. PubMed ID: 19461242
[TBL] [Abstract][Full Text] [Related]
12. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
Feldman AL; Law M; Remstein ED; Macon WR; Erickson LA; Grogg KL; Kurtin PJ; Dogan A
Leukemia; 2009 Mar; 23(3):574-80. PubMed ID: 18987657
[TBL] [Abstract][Full Text] [Related]
13. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
Verma A; Epari S; Gujral S; Shet T
Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
[TBL] [Abstract][Full Text] [Related]
14. 9p21 deletion in primary cutaneous large B-cell lymphoma, leg type, may escape detection by standard FISH assays.
Wiesner T; Obenauf AC; Geigl JB; Vallant EM; Speicher MR; Fink-Puches R; Kerl H; Cerroni L
J Invest Dermatol; 2009 Jan; 129(1):238-40. PubMed ID: 18704105
[No Abstract] [Full Text] [Related]
15. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
Giménez S; Costa C; Espinet B; Solé F; Pujol RM; Puigdecanet E; García-Moreno P; Sánchez J; Gallardo F; Estrach T; García-Muret P; Romagosa V; Serrano S; Servitje O
Exp Dermatol; 2005 Dec; 14(12):883-90. PubMed ID: 16274455
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.
Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O
J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504
[TBL] [Abstract][Full Text] [Related]
18. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
[TBL] [Abstract][Full Text] [Related]
19. Refractory IGκ/IRF4-positive DLBCL with CDKN2A/2B deletion.
Chonabayashi K; Tamori S; Taniwaki M; Fujita H; Shimazu Y; Matsui Y; Hishizawa M; Usami K; Takaori-Kondo A
Ann Hematol; 2014 May; 93(5):893-4. PubMed ID: 23989669
[No Abstract] [Full Text] [Related]
20. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
